Armando Morera Fumero-rekin lankidetzan egindako argitalpenak (24)

2023

  1. Serum s100b protein levels as a neuroinflammatory biomarker of acutely relapsed paranoid schizophrenia patients

    Acta Neuropsychiatrica, Vol. 35, Núm. 3, pp. 138-146

2021

  1. Acute paranoid schizophrenia relapsed inpatients present summer/ winter but not day/night changes in serum S100B concentrations

    Actas Espanolas de Psiquiatria, Vol. 49, Núm. 5, pp. 211-215

2020

  1. Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review

    Drug and Alcohol Dependence, Vol. 212

2019

  1. Descriptive study of diving injuries in the Canary Islands from 2008 to 2017

    Diving and hyperbaric medicine, Vol. 49, Núm. 3, pp. 204-208

  2. Psychiatric Symptoms and Sex-related Differences in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries

    Revista Espanola de Cardiologia, Vol. 72, Núm. 8, pp. 686-688

2018

  1. Day/night and summer/winter changes in serum total antioxidant capacity

    Medicinal Chemistry, Vol. 14, Núm. 3, pp. 225-229

2017

  1. A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia

    PLoS ONE, Vol. 12, Núm. 12

  2. Day/night changes in serum S100B protein concentrations in acute paranoid schizophrenia

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 75, pp. 207-212

  3. Low levels of serum total antioxidant capacity and presence at admission and absence at discharge of a day/night change as a marker of acute paranoid schizophrenia relapse

    Psychiatry Research, Vol. 249, pp. 200-205

2015

  1. Síntomas psiquiátricos y dimensiones de personalidad en pacientes menores de 65 años ingresados por un síndrome coronario agudo

    Revista Espanola de Cardiologia

2013

  1. Chronotype as modulator of morning serum melatonin levels

    Actas Espanolas de Psiquiatria, Vol. 41, Núm. 3, pp. 149-153

  2. Prognostic Value of Malondialdehyde Serum Levels in Severe Sepsis: A Multicenter Study

    PLoS ONE, Vol. 8, Núm. 1

  3. Role of melatonin in schizophrenia

    International Journal of Molecular Sciences, Vol. 14, Núm. 5, pp. 9037-9050

  4. S100B and schizophrenia

    Psychiatry and Clinical Neurosciences, Vol. 67, Núm. 2, pp. 67-75

  5. Summer/winter changes in serum S100B protein concentration as a source of research variance

    Journal of Psychiatric Research, Vol. 47, Núm. 6, pp. 791-795

2010

  1. Diazepam discontinuation through agomelatine in schizophrenia with insomnia and depression

    Journal of Clinical Psychopharmacology

2009

  1. Morningness-eveningness personality traits and melatonin levels

    World J. Biol Psychiatry, Vol. 10, Núm. Suppl. 1, pp. 440

  2. Night-time/daytime and daytime/daytime patterns of melatonin levels

    European Neuropsychopharmacology, Vol. 19 - (Supplement 3)

  3. Trazodone hypnotic effect and nocturnal melatonin secretion

    Journal of Clinical Psychopharmacology

  4. Winter/summer seasonal changes in malondialdehyde formation as a source of variance in oxidative stress schizophrenia research

    World Journal of Biological Psychiatry, Vol. 10, Núm. 4 PART 2, pp. 576-580